In this study, we have determined the multifaceted roles of Tcf7l2, one of the strongest genetic determinants for T2D in humans (Hansen et al., 2011) and in the development of MetS upon olanzapine challenge in mice. The gene discussed is TCF7L2; the disease is metabolic syndrome.